Sanford Zweifach

Sanford S.
Zweifach was the founder of Ascendancy Healthcare, Inc., founded in 2011, where the title held was Chief Executive Officer in 2015.
Mr. Zweifach was the founder of Nuvelution Pharma, Inc., founded in 2015, where the titles held were President, Chief Executive Officer & Director from 2015 to 2019.
Current jobs include CEO, Chief Financial Officer, Secretary & Director at Pelican Group Consulting, Inc.; Chairman at Lyric Pharmaceuticals, Inc. since 2015; Chairman at CTx Operations, Inc. since 2021; Independent Non-Executive Director at Compugen Ltd. since 2018; President, Director & Chief Business Officer at Imidomics, Inc. since 2019; Director at Syndexis SARL; and Venture Partner at Medicxi Ventures (Jersey) Ltd. since 2020.
Former jobs include Chief Executive Officer at Pathway Diagnostics Ltd.; Executive Chairman at Janpix Holdings, Inc.; Executive Chairman at Kaerus Bioscience Ltd.; Chairman at Carisma Therapeutics, Inc. from 2021 to 2025; Independent Director at Anthera Pharmaceuticals, Inc. from 2013 to 2016; Independent Non-Executive Director at Realm Therapeutics Plc from 2017 to 2019; Chief Financial Officer & Managing Director at Bay City Capital LLC; Director at Viventia Bio, Inc.; Director at Palladio Biosciences, Inc. from 2019 to 2021; Independent Director at ESSA Pharma, Inc. from 2019 to 2025; President & Chief Financial Officer at Epoch Biosciences, Inc.; and Partner at Reedland Capital Partner.
Education includes graduate degree from the University of California, Davis in 1984 and undergraduate degree from the University of California San Diego in 1978.